RxDoctor Payments Data

Pamela Murray

Adult Health · Havertown, PANPI 1821510694

Payments from drug & device makers

$1,143in general payments, 2019–2025

Across 61 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$194
  • Merck$127
  • Boehringer Ingelheim$124
  • Lilly USA, LLC$113
  • AstraZeneca$108
  • AbbVie$87
  • plus $391 from 9 others

What the payments were for

  • Food & beverage$1,143100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,143 in reported general payments places this provider in the 70th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$58,085
Medicare patients
343
Services billed
778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala26$51,627
JardianceEmpagliflozin23$37,563
EliquisApixaban32$30,028
TrulicityDulaglutide11$10,543
SimbrinzaBrinzolamide/Brimonidine Tart14$3,286
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$2,300
Atorvastatin Calcium194$1,867
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,493
Nifedipine ErNifedipine50$1,276
Mirtazapine42$1,266
Metoprolol Succinate134$1,232
Amlodipine Besylate211$1,138
Azelastine Hcl39$1,090
Rosuvastatin Calcium60$1,053
Pregabalin16$987

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$124$37,56323 claims
PfizerEliquis$57$30,02832 claims
Lilly USA, LLCTrulicity$113$10,54311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Havertown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →